作者: Shawn M. Jensen , Bernard A. Fox
关键词: Antibody 、 Medicine 、 IL-2 receptor 、 Cancer research 、 Cancer vaccine 、 Perforin 、 Tumor necrosis factor alpha 、 Fludarabine 、 Adoptive cell transfer 、 CD8
摘要: From our perspective a great deal has changed in the past few years. We now appreciate that tumor-specific T cells have at least triad of properties (perforin, IFN-γ, and TNF) they can utilize to mediate tumor regression. also basic understanding vitro methods polarize primed towards “therapeutic” type 1 cytokine profile (IFN-γ TNF). Additionally, combining vaccination time when host are undergoing homeostasis-driven proliferation been shown dramatically increase frequency generated by host. The discovery CD25+CD4+ regulatory sites success adoptive transfer CD4 CD8+ TIL with non myeloablative conditioning regimen includes fludarabine, drug preferentially decimates CD4+ cells, likely be related. availability antibodies or ligands block negative signals (CTLA4) provide costimulatory (4-1BB, OX40) will extended initiated soon. next several years should prove particularly informative as trials incorporating combinations strategies make their way clinic.